Individual skill

nature-biotechnology

Use when targeting Nature Biotechnology or deciding whether a biotechnology/enabling-methods manuscript fits this venue. Encodes the journal's fit, framing, method-and-evidence bar, house style, official-submission re-check, and desk-reject heuristics.

English-NaturalScience-Journal-Skills/skills/nature-biotechnology/SKILL.md

Read pinned source

Source commit 932eb23331721b16e967c59f093781be1928b498

What was checked

Matches the observed repository HEAD
Yes
Scanner rules are current
Yes
Repository scan complete
No
Skill scan complete
Yes
Observed behavior
Network or broad shell
Last checked
Nov 9, 2026

These are observations at the recorded commit, not a guarantee of safety. Review the source before running it.

Install this skill

Choose an agent in your Stack or copy a command below. Commands fetch the pinned commit and copy only this skill directory. Existing destinations are refused. Copying a command does not install anything.

An install command is unavailable: current rules, complete repository and skill scans, an eligible behavior level and a permitted license are required.

Repository context

Repository stars (not skill ratings)
1,405
Repository last updated
Sep 27, 2026
License
MIT

Observed agent integration: No specific integration evidence. Standard SKILL.md installation does not imply verified compatibility.

Files and excerpt

File metadata and permitted, redacted excerpts come from the recorded scan. Source links are pinned to that commit.

Browse files
Read excerpt

# Nature Biotechnology (nature-biotechnology)

## Journal positioning

Nature Biotechnology is the Nature Portfolio's venue for enabling technologies, platforms, and methods that have broad applied impact across biological research, medicine, or industry — with the distinguishing emphasis on translational potential and broad adoption at scale. Where Nature Methods' primary criterion is generalizable methodological advance for research, Nature Biotechnology additionally asks whether the technology could be (or already is) transformative for a wider application domain: therapeutics, diagnostics, agriculture, bioindustrial production, or research infrastructure. Papers must demonstrate both technical rigor and a compelling case for broad utility. The readership spans researchers, clinicians, engineers, and industry scientists.

This skill is a **fit / venue-selection / re-framing** tool. It does not replace the journal's current official submission guidelines. Before submitting, re-check the live author instructions on the Nature Portfolio site or submission system.

## When to trigger

- The author names Nature Biotechnology as the target venue.
- A new platform technology, cell-engineering approach, or therapeutic tool is being assessed for venue fit against Nature Methods, Nature Medicine, or Cell Chemical Biology.
- A study delivering a biotechnological platform with demonstrated in vivo proof-of-concept needs to assess its significance level.
- The author needs Nature Biotechnology's specific desk-reject risks and re-routing options.
Back to top